| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of NT5E mRNA | CTD | PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of NT5E mRNA | CTD | PMID:22298810 PMID:22574217 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of NT5E mRNA | CTD | PMID:20106945 PMID:21632981 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:62249 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of NT5E mRNA | CTD | PMID:19933214 PMID:21889950 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of NT5E mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:62249 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of NT5E mRNA | CTD | PMID:21354282 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:62249 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of NT5E mRNA | CTD | PMID:19933214 |
| 3,3',5-triiodo-L-thyronine | increases expression | ISO | RGD:61956 | 6480464 | Triiodothyronine results in increased expression of NT5E mRNA | CTD | PMID:15543949 |
| 3,3',5-triiodo-L-thyronine | increases activity | ISO | RGD:61956 | 6480464 | Triiodothyronine results in increased activity of NT5E protein | CTD | PMID:15543949 |
| 4,4'-diaminodiphenylmethane | affects expression | ISO | RGD:62249 | 6480464 | 4,4'-diaminodiphenylmethane affects the expression of NT5E mRNA | CTD | PMID:18648102 |
| 5-aza-2'-deoxycytidine | increases expression | EXP | | 6480464 | decitabine results in increased expression of NT5E mRNA | CTD | PMID:16367923 |
| ADP | decreases activity | EXP | | 6480464 | Adenosine Diphosphate analog results in decreased activity of NT5E protein | CTD | PMID:18404487 |
| aflatoxin B1 | decreases expression | ISO | RGD:62249 | 6480464 | Aflatoxin B1 results in decreased expression of NT5E mRNA | CTD | PMID:19770486 |
| antimycin A | increases expression | ISO | RGD:62249 | 6480464 | Antimycin A results in increased expression of NT5E mRNA | CTD | PMID:19304788 |
| bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of NT5E mRNA | CTD | PMID:22576693 |
| bisphenol A | decreases methylation | EXP | | 6480464 | bisphenol A results in decreased methylation of NT5E gene | CTD | PMID:22576693 |
| choline | multiple interactions | ISO | RGD:62249 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NT5E mRNA | CTD | PMID:20938992 |
| ciguatoxin CTX1B | affects expression | ISO | RGD:62249 | 6480464 | Ciguatoxins affects the expression of NT5E mRNA | CTD | PMID:18353800 |
| cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of NT5E mRNA | CTD | PMID:19376846 |
| cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of NT5E mRNA | CTD | PMID:17553155 PMID:19376846 |
| copper atom | decreases expression | ISO | RGD:61956 | 6480464 | Copper results in decreased expression of NT5E mRNA | CTD | PMID:22465980 |
| copper(0) | decreases expression | ISO | RGD:61956 | 6480464 | Copper results in decreased expression of NT5E mRNA | CTD | PMID:22465980 |
| coumestrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NT5E mRNA | CTD | PMID:19167446 |
| coumestrol | decreases expression | EXP | | 6480464 | Coumestrol results in decreased expression of NT5E mRNA | CTD | PMID:19167446 |
| crocidolite asbestos | increases expression | EXP | | 6480464 | Asbestos, Crocidolite results in increased expression of NT5E mRNA | CTD | PMID:18687144 |
| cyclosporin A | affects expression | EXP | | 6480464 | Cyclosporine affects the expression of NT5E mRNA | CTD | PMID:20106945 |
| cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of NT5E mRNA | CTD | PMID:21632981 |
| Delta(9)-tetrahydrocannabinol | increases expression | ISO | RGD:61956 | 6480464 | Tetrahydrocannabinol results in increased expression of NT5E mRNA | CTD | PMID:16616335 |
| diarsenic trioxide | decreases expression | EXP | | 6480464 | arsenic trioxide results in decreased expression of NT5E mRNA | CTD | PMID:22521957 |
| dibutyl phthalate | increases expression | ISO | RGD:62249 | 6480464 | Dibutyl Phthalate results in increased expression of NT5E mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | increases expression | ISO | RGD:62249 | 6480464 | Dibutyl Phthalate results in increased expression of NT5E mRNA | CTD | PMID:17361019 PMID:21266533 |
| dibutyl phthalate | increases expression | ISO | RGD:61956 | 6480464 | Dibutyl Phthalate results in increased expression of NT5E mRNA | CTD | PMID:21266533 |
| dioxygen | increases expression | ISO | RGD:62249 | 6480464 | Oxygen deficiency results in increased expression of NT5E mRNA | CTD | PMID:20880076 |
| ethanol | increases expression | ISO | RGD:61956 | 6480464 | Ethanol results in increased expression of NT5E mRNA | CTD | PMID:17920746 |
| ethanol | affects expression | ISO | RGD:62249 | 6480464 | Ethanol affects the expression of NT5E mRNA | CTD | PMID:19167417 |
| folic acid | multiple interactions | ISO | RGD:62249 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NT5E mRNA | CTD | PMID:20938992 |
| furan | increases methylation | ISO | RGD:61956 | 6480464 | furan results in increased methylation of NT5E gene | CTD | PMID:22079235 |
| indomethacin | multiple interactions | EXP | | 6480464 | Indomethacin results in increased expression of and results in increased activity of NT5E protein | CTD | PMID:17568578 |
| indomethacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of NT5E mRNA | CTD | PMID:17568578 |
| L-methionine | multiple interactions | ISO | RGD:62249 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NT5E mRNA | CTD | PMID:20938992 |
| paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of NT5E mRNA | CTD | PMID:21420995 |
| paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of NT5E mRNA | CTD | PMID:21420995 PMID:22230336 |
| paraquat | increases expression | ISO | RGD:62249 | 6480464 | Paraquat results in increased expression of NT5E mRNA | CTD | PMID:12595580 |
| perfluorooctane-1-sulfonic acid | affects expression | ISO | RGD:62249 | 6480464 | perfluorooctane sulfonic acid affects the expression of NT5E mRNA | CTD | PMID:19429403 |
| perfluorooctanoic acid | affects expression | ISO | RGD:62249 | 6480464 | perfluorooctanoic acid affects the expression of NT5E mRNA | CTD | PMID:19429403 |
| phenobarbital | increases expression | ISO | RGD:62249 | 6480464 | Phenobarbital results in increased expression of NT5E mRNA | CTD | PMID:19482888 |
| phenobarbital | affects expression | ISO | RGD:62249 | 6480464 | Phenobarbital affects the expression of NT5E mRNA | CTD | PMID:23091169 |
| phenobarbital | multiple interactions | ISO | RGD:62249 | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of NT5E mRNA] | CTD | PMID:19482888 |
| pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of NT5E mRNA | CTD | PMID:19710929 |
| pirinixic acid | increases expression | ISO | RGD:61956 | 6480464 | pirinixic acid results in increased expression of NT5E mRNA | CTD | PMID:16940010 |
| pirinixic acid | decreases expression | ISO | RGD:62249 | 6480464 | pirinixic acid results in decreased expression of NT5E mRNA | CTD | PMID:17426115 |
| pirinixic acid | increases expression | ISO | RGD:62249 | 6480464 | pirinixic acid results in increased expression of NT5E mRNA | CTD | PMID:20813756 |
| pirinixic acid | multiple interactions | ISO | RGD:62249 | 6480464 | [pirinixic acid co-treated with PPARA] results in increased expression of NT5E mRNA | CTD | PMID:20813756 |
| quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of NT5E mRNA | CTD | PMID:17643826 |
| quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of NT5E mRNA | CTD | PMID:17643826 PMID:21632981 |
| quercetin | decreases activity | EXP | | 6480464 | Quercetin results in decreased activity of NT5E protein | CTD | PMID:17643826 |
| rotenone | increases expression | ISO | RGD:62249 | 6480464 | Rotenone results in increased expression of NT5E mRNA | CTD | PMID:19304788 |
| sodium dichromate | decreases expression | ISO | RGD:62249 | 6480464 | sodium bichromate results in decreased expression of NT5E mRNA | CTD | PMID:22155349 |
| sodium dichromate | decreases expression | ISO | RGD:61956 | 6480464 | sodium bichromate results in decreased expression of NT5E mRNA | CTD | PMID:22561333 |
| testosterone | decreases expression | ISO | RGD:62249 | 6480464 | Testosterone results in decreased expression of NT5E mRNA | CTD | PMID:15788153 more ... |
| testosterone | decreases expression | ISO | RGD:62249 | 6480464 | Testosterone results in decreased expression of NT5E mRNA | CTD | PMID:20844152 more ... |
| testosterone | decreases expression | ISO | RGD:62249 | 6480464 | Testosterone results in decreased expression of NT5E mRNA | CTD | PMID:21669218 more ... |
| testosterone | decreases expression | ISO | RGD:62249 | 6480464 | Testosterone results in decreased expression of NT5E mRNA | CTD | PMID:21669218 more ... |
| testosterone | decreases expression | ISO | RGD:62249 | 6480464 | Testosterone results in decreased expression of NT5E mRNA | CTD | PMID:15788153 more ... |
| tetrachloromethane | multiple interactions | ISO | RGD:62249 | 6480464 | NT5E gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of IL13RA2 mRNA]; more ... | CTD | PMID:18263696 |
| tetrachloromethane | affects expression | ISO | RGD:62249 | 6480464 | Carbon Tetrachloride affects the expression of NT5E mRNA | CTD | PMID:17484886 |
| tetrachloromethane | increases response to substance | ISO | RGD:62249 | 6480464 | NT5E protein results in increased susceptibility to Carbon Tetrachloride | CTD | PMID:18263696 |
| thioacetamide | increases response to substance | ISO | RGD:62249 | 6480464 | NT5E protein results in increased susceptibility to Thioacetamide | CTD | PMID:18263696 |
| uranium atom | affects expression | EXP | | 6480464 | Uranium affects the expression of NT5E mRNA | CTD | PMID:15672453 |